About
Contact & Profiles
A5030665877
Research Areas
- Research on Leishmaniasis Studies
- Synthesis and Biological Evaluation
- Parasitic Infections and Diagnostics
- Quinazolinone synthesis and applications
- Parasites and Host Interactions
- Trypanosoma species research and implications
- Helminth infection and control
- Parasitic infections in humans and animals
- Synthesis and biological activity
- Parasitic Diseases Research and Treatment
- Crystallization and Solubility Studies
- Computational Drug Discovery Methods
- Amoebic Infections and Treatments
- Biochemical and Molecular Research
- Insects and Parasite Interactions
- Cannabis and Cannabinoid Research
- Insect and Pesticide Research
- X-ray Diffraction in Crystallography
- Parasite Biology and Host Interactions
- Neurotransmitter Receptor Influence on Behavior
- Calcium signaling and nucleotide metabolism
- Free Radicals and Antioxidants
- Veterinary medicine and infectious diseases
- Drug Solubulity and Delivery Systems
- Phenothiazines and Benzothiazines Synthesis and Activities
Universidad Nacional Autónoma de México
2014-2024
Instituto Nacional de Perinatología
2020
10.1016/s0960-894x(02)00346-3
article
EN
Bioorganic & Medicinal Chemistry Letters
2002-08-01
10.1016/s0960-894x(00)00619-3
article
EN
Bioorganic & Medicinal Chemistry Letters
2001-01-01
10.1016/j.ejmech.2010.03.050
article
EN
European Journal of Medicinal Chemistry
2010-04-12
10.1016/j.ejmech.2015.04.028
article
EN
European Journal of Medicinal Chemistry
2015-04-15
10.1016/j.ejmech.2005.09.001
article
EN
European Journal of Medicinal Chemistry
2005-11-03
10.1016/j.jmgm.2013.01.007
article
EN
Journal of Molecular Graphics and Modelling
2013-02-09
10.1016/j.bmcl.2013.05.012
article
EN
Bioorganic & Medicinal Chemistry Letters
2013-05-15
10.1016/s0968-0896(03)00497-8
article
EN
Bioorganic & Medicinal Chemistry
2003-09-12
10.1016/j.bmc.2008.12.059
article
EN
Bioorganic & Medicinal Chemistry
2009-01-03
10.1016/j.ejmech.2013.07.054
article
EN
European Journal of Medicinal Chemistry
2013-08-16
10.1016/j.ejmech.2014.12.051
article
EN
European Journal of Medicinal Chemistry
2014-12-29
10.1016/j.bmc.2016.04.007
article
EN
Bioorganic & Medicinal Chemistry
2016-04-03
10.1016/j.ejmech.2014.09.027
article
EN
European Journal of Medicinal Chemistry
2014-09-09
10.1016/j.actatropica.2008.11.014
article
EN
Acta Tropica
2008-12-03
10.1016/j.bmcl.2011.10.028
article
EN
Bioorganic & Medicinal Chemistry Letters
2011-10-17
10.1016/j.actatropica.2011.12.009
article
EN
Acta Tropica
2011-12-27
10.1016/j.ejmech.2012.03.014
article
EN
European Journal of Medicinal Chemistry
2012-03-16
10.1016/j.bmcl.2013.10.011
article
EN
Bioorganic & Medicinal Chemistry Letters
2013-10-10
10.1016/j.ejmech.2015.06.010
article
EN
European Journal of Medicinal Chemistry
2015-06-06
10.1016/j.jep.2010.07.009
article
EN
Journal of Ethnopharmacology
2010-07-14
10.1016/j.bbamem.2011.11.026
article
EN
publisher-specific-oa
Biochimica et Biophysica Acta (BBA) - Biomembranes
2011-12-08
Abstract In this research work, a series of 16 quinazoline derivatives bearing ibuprofen and an amino acid were designed as inhibitors epidermal growth factor receptor tyrosine kinase domain (EGFR‐TKD) cyclooxygenase‐2 (COX‐2) with the intention presenting dual action in their biological behavior. The compounds synthesized assessed for cytotoxicity on epithelial cancer cells lines (AGS, A‐431, MCF‐7, MDA‐MB‐231) non‐tumorigenic cell line (HaCaT). From evaluation, derivative 6 was observed to...
10.1002/cmdc.202300651
article
EN
cc-by-nc-nd
ChemMedChem
2024-02-14
10.1016/j.ejmech.2008.05.005
article
EN
European Journal of Medicinal Chemistry
2008-05-16
10.1016/j.biocel.2009.11.005
article
EN
The International Journal of Biochemistry & Cell Biology
2009-11-14
10.1016/j.ejmech.2011.05.016
article
EN
European Journal of Medicinal Chemistry
2011-05-20
Coming Soon ...